DiscoverBulls & Betrayal#033 $GSK’s Zantac Fallout Buried Cancer Risks and Billions in Liability
#033 $GSK’s Zantac Fallout Buried Cancer Risks and Billions in Liability

#033 $GSK’s Zantac Fallout Buried Cancer Risks and Billions in Liability

Update: 2025-06-15
Share

Description

GlaxoSmithKline $GSK allegedly hid a decades-old report showing its blockbuster drug Zantac could form a cancer-causing compound far beyond safe limits. Now, a securities class action says $GSK misled investors for years while lawsuits mounted. In this explosive episode of Bulls and Betrayal, Anna and Nate expose the cover-up, the internal science, and the $2.3B market hit. For pharma investors, legal junkies, and anyone who’s ever trusted a drug label.


We’re not lawyers or accountants, so don’t take this as legal or financial advice.


🔬 Read the full case at ZLK.com | Follow @bullsandbetrayal




$GSK GlaxoSmithKline Zantac NDMA cancer lawsuit drug recall pharma scandal securities fraud shareholder class action FDA litigation whistleblower toxic risk disclosure Emma Walmsley Rule 10b5

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

#033 $GSK’s Zantac Fallout Buried Cancer Risks and Billions in Liability

#033 $GSK’s Zantac Fallout Buried Cancer Risks and Billions in Liability

bullsandbetrayal